“From Gut to Gonads: A Rare Journey of Jejunal Neuroendocrine Tumor to the Testis”
Authors
Associate Professor, Department of Pathology, K H Patil Institute of Medical Sciences (Formerly called as Gadag Institute of Medical Sciences), Gadag, Karnataka (India)
Assistant Professor, Department of Pathology, K H Patil Institute of Medical Sciences (Formerly called as Gadag Institute of Medical Sciences), Gadag, Karnataka (India)
Postgraduate Resident, Department of Pathology, K H Patil Institute of Medical Sciences (Formerly called as Gadag Institute of Medical Sciences), Gadag, Karnataka (India)
Professor & Head of the Department of Pathology, K H Patil Institute of Medical Sciences (Formerly called as Gadag Institute of Medical Sciences), Gadag, Karnataka (India)
Article Information
Publication Timeline
Submitted: 2026-02-14
Accepted: 2026-02-20
Published: 2026-03-02
Abstract
Neuroendocrine tumors (NETs) are uncommon epithelial neoplasms originating from neuroendocrine cells, within the gastrointestinal tract—particularly the jejunum and ileum, being the most frequent primary sites. While NETs account for approximately 0.5% of all malignancies, metastatic spread occurs in about 30% of cases, most commonly to the liver. Testicular metastasis from NETs is extremely rare, representing less than 1% of testicular tumors. We report a rare case of 65-year-old male who presented with a painless right scrotal swelling. Imaging revealed a well-defined hypervascular testicular mass and a similar lesion in the midjejunum with mesenteric involvement. The patient underwent segmental jejunal resection and right high inguinal orchidectomy. Histopathology and immunohistochemistry confirmed the diagnosis of a welldifferentiated - Grade I -jejunal NET with testicular metastasis.
Keywords
Neuroendocrine tumor (NET), Jejunum, Testis, Metastasis, Orchidectomy
Downloads
References
1. Klimstra DS, Klöppel G, La Rosa S, Rindi GW. Classification of neuroendocrine neoplasms of the digestive system. WHO Classification of tumours, 5th Edition. Digestive system tumours. 2019 Sep 1:16-9. doi: 10.1111/his.13975. [Google Scholar] [Crossref]
2. Lloyd RV, Osamura RY, Klöppel G, Rosai J. WHO Classification of Tumours of Endocrine Organs, 4th ed., IARC: Lyon, 2017. doi: 10.1007/s00401-017-1769-8. [Google Scholar] [Crossref]
3. Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer. 1997 Feb 15;79(4):81329. doi:10.1002/(SICI)1097-0142(19970215)79:4<813::AID-CNCR19>3.0.CO;2-2. [Google Scholar] [Crossref]
4. Akbar SA, Sayyed TA, Jafri SZ, Hasteh F, Neill JS. Multimodality imaging of paratesticular neoplasms and their rare mimics. Radiographics. 2003 Nov;23(6):1461-76. doi: 10.1148/rg.236025174. [Google Scholar] [Crossref]
5. Eichhorn JH, Young RH. Neuroendocrine tumors of the genital tract. Pathology Patterns Reviews. 2001 Jun 1;115(suppl_1):S94-112. doi: 10.1309/64CW-WKGK-49EF-BYD1. [Google Scholar] [Crossref]
6. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. Journal of clinical oncology. 2008 Jun 20;26(18):3063-72. doi: 10.1200/JCO.2007.15.4377. [Google Scholar] [Crossref]
7. Ulbright TM, Young RH. Metastatic carcinoma to the testis: a clinicopathologic analysis of 26 cases. Am J Surg Pathol. 2008;32(11):1683–1693. [Google Scholar] [Crossref]
8. Strosberg J. Neuroendocrine tumours of the small intestine. Best practice & research Clinical gastroenterology. 2012 Dec 1;26(6):755-73. doi: 10.1016/j.bpg.2012.12.002. [Google Scholar] [Crossref]
9. Modlin IM, Oberg K, Chung DC, et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 2008;9(1):61–72. [Google Scholar] [Crossref]
10. Oronsky B, Ma PC, Morgensztern D, Carter CA. Nothing but NET: a review of neuroendocrine tumors and carcinomas. Neoplasia. 2017 Dec 1;19(12):991-1002. doi: 10.1016/j.neo.2017.09.002. [Google Scholar] [Crossref]
11. Parghane RV, Basu S. Testicular Metastasis From Neuroendocrine Tumors: Imaging and Theranostics Through: 68: Ga-DOTATATE PET/CT and: 177: Lu-DOTATATE–Based Peptide Receptor Radionuclide Therapy. Clinical Nuclear Medicine. 2023 Dec 1;48(12):1051-2. doi: 10.1097/RLU.0000000000004846. [Google Scholar] [Crossref]
12. Amine MM, Mohamed B, Mourad H, Majed H, Slim C, Mehdi B, Hela M, Nouri R, Rim K, Tahya B, Nabil MM. Neuroendocrine testicular tumors: a systematic review and meta-analysis. Current Urology. 2017 Mar 30;10(1):15-25. doi: 10.1159/000447146. [Google Scholar] [Crossref]